TRIA, an architectural firm based in Boston, has recently announced the completion of Korro Bio’s new headquarters located in Cambridge, MA. The impressive office and laboratory fit-out spans over 50,000 square feet and serves as a significant milestone for the biopharmaceutical company specializing in RNA-based genetic medicines. This project was completed ahead of schedule and under budget.
Korro Bio is dedicated to developing therapies for patients with rare or highly prevalent diseases. As they continue to grow their business, they sought a space that would reflect their innovative mission while accommodating their expanding team. The newly designed headquarters includes open work environments that promote flexibility and collaboration among employees as well as dynamic meeting hubs and lab spaces intended to foster creativity and scientific discovery.
According to Amanda Roderman, project manager at TRIA: “This project was a successful collaboration between Korro Bio’s leadership team and our design experts.” She further explains that the goal was not only to create an environment that reflects Korro Bio’s cutting-edge work but also provides employees with a comfortable yet dynamic place where they can thrive.
In conclusion,TRIA has successfully completed the fit-out for Korro Bio’s new headquarters in Cambridge – providing them with an innovative space tailored specifically towards promoting growth within their industry.
